BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naderi A, Hughes-Davies L. Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer. J Cancer Res Clin Oncol 2009;135:211-6. [PMID: 18716795 DOI: 10.1007/s00432-008-0455-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Naderi A. Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies. Exp Cell Res 2019;376:221-6. [PMID: 30779920 DOI: 10.1016/j.yexcr.2019.02.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Fang Z, Han B, Jung KH, Lee J, El-damasy AK, Gadhe CG, Kim SJ, Yan HH, Park JH, Lee JE, Kang YW, Pae AN, Keum G, Hong S. A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer. Cancer Letters 2018;426:25-36. [DOI: 10.1016/j.canlet.2018.03.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Noh SJ, Kim KM, Jang KY. Individual and co-expression patterns of nerve growth factor and heme oxygenase-1 predict shorter survival of gastric carcinoma patients. Diagn Pathol. 2017;12:48. [PMID: 28679437 DOI: 10.1186/s13000-017-0644-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
4 Shargh VH, Hondermarck H, Liang M. Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy. Nanomedicine (Lond) 2017;12:977-89. [PMID: 28440712 DOI: 10.2217/nnm-2016-0419] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
5 Osipov AV, Utkin YN. Antiproliferative Effects of Snake Venom Phospholipases A2 and Their Perspectives for Cancer Treatment. Toxins and Drug Discovery 2017. [DOI: 10.1007/978-94-007-6452-1_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Shargh VH, Hondermarck H, Liang M. Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion. International Journal of Pharmaceutics 2016;515:527-34. [DOI: 10.1016/j.ijpharm.2016.10.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
7 Osipov AV, Utkin YN. Antiproliferative Effects of Snake Venom Phospholipases A2 and Their Perspectives for Cancer Treatment. Toxins and Drug Discovery 2015. [DOI: 10.1007/978-94-007-6726-3_13-1] [Reference Citation Analysis]
8 Noh SJ, Bae JS, Jamiyandorj U, Park HS, Kwon KS, Jung SH, Youn HJ, Lee H, Park BH, Chung MJ. Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients. BMC Cancer. 2013;13:516. [PMID: 24180625 DOI: 10.1186/1471-2407-13-516] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
9 Hondermarck H. Neurotrophins and their receptors in breast cancer. Cytokine & Growth Factor Reviews 2012;23:357-65. [DOI: 10.1016/j.cytogfr.2012.06.004] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 6.9] [Reference Citation Analysis]
10 Naderi A, Chia KM, Liu J. Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer. Breast Cancer Res 2011;13:R36. [PMID: 21457548 DOI: 10.1186/bcr2858] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
11 . References. Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy 2011. [DOI: 10.1016/b978-0-12-387819-9.00029-3] [Reference Citation Analysis]
12 Naderi A, Liu J. Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer. Cancer Lett. 2010;298:74-87. [PMID: 20605569 DOI: 10.1016/j.canlet.2010.06.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]